These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6621482)

  • 1. Effect of food on cefaclor bioavailability in children.
    Shanker SA; Baird-Lamber J; Cvejic M; Buchanan N
    Med J Aust; 1983 Oct; 2(8):372. PubMed ID: 6621482
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased absorption of cefaclor in short bowel syndrome.
    Nahata MC; Freimer N; Hilty MD
    Drug Intell Clin Pharm; 1983 Mar; 17(3):201-2. PubMed ID: 6839944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
    Lode H; Köppe P; Stahlmann R
    Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.
    Ginsburg CM
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():27-31. PubMed ID: 7142090
    [No Abstract]   [Full Text] [Related]  

  • 5. Penetration of cefaclor to adenoid tissue and middle ear effusion in chronic OME.
    Ernstson S; Anari M; Edén T; Sundberg L
    Acta Otolaryngol Suppl; 1985; 424():7-12. PubMed ID: 3865494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review [new antibiotics series V]: cefaclor (author's transl)].
    Fujii R
    Jpn J Antibiot; 1982 Mar; 35(3):714-23. PubMed ID: 7047791
    [No Abstract]   [Full Text] [Related]  

  • 8. Cefaclor pharmacokinetics and renal impairment.
    Fillastre JP; Leroy A; Humbert G; Godin M
    J Antimicrob Chemother; 1980 Jan; 6(1):155-6. PubMed ID: 7358611
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and sputum levels of cefaclor.
    Simon C; Gatzemeier U
    Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefaclor in chronic middle ear effusions.
    Lildholdt T; Cantekin EI; Marshak G; Bluestone CD; Rohn DD; Schuit KE
    Ann Otol Rhinol Laryngol Suppl; 1981; 90(3 Pt 3):44-7. PubMed ID: 6791562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological study of cefaclor in the newborn infant.
    Chin KC; Kerr MM; Cockburn F; McAllister TA
    Curr Med Res Opin; 1981; 7(3):168-70. PubMed ID: 7194171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.
    Hampel B; Lode H; Wagner J; Koeppe P
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1061-3. PubMed ID: 7159069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigations on the excretion of cefaclor in human bile (author's transl)].
    Müller O; Rückert U; Fabricius K
    Infection; 1979; 7 Suppl 6():624-7. PubMed ID: 551091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of cefaclor in subjects with normal renal function and in uraemic patients (author's transl)].
    Leroy A; Humbert G; Fillastre JP
    Therapie; 1981; 36(5):533-40. PubMed ID: 7323991
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
    Ginsburg CM; McCracken GH
    J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration of cefaclor in human prostatic tissue.
    Smith RP; Schmid GP; Baltch AL; Sutphen NT; Hammer MC
    Am J Med Sci; 1981; 281(1):19-24. PubMed ID: 7468636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
    Gartenberg G; Meyers BR; Hirschmann SZ; Srulevitch E
    J Antimicrob Chemother; 1979 Jul; 5(4):465-70. PubMed ID: 489494
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
    Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
    Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.